BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30640063)

  • 21. Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination.
    Lee SY; Chung SK
    Stem Cell Res; 2019 Dec; 41():101649. PubMed ID: 31731184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
    Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
    Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease.
    Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
    Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
    Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
    Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
    Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 May; 45():101781. PubMed ID: 32305865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and characterization of a human iPSC line from a patient with propionic acidemia due to defects in the PCCA gene.
    Alonso-Barroso E; Brasil S; Briso-Montiano Á; Navarrete R; Pérez-Cerdá C; Ugarte M; Pérez B; Desviat LR; Richard E
    Stem Cell Res; 2017 Aug; 23():173-177. PubMed ID: 28925364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease.
    Dulovic-Mahlow M; Lukomska A; Diaw SH; Balck A; Borsche M; Grütz K; Lenz I; Rudolph F; Lohmann K; Klein C; Seibler P
    Stem Cell Res; 2019 Dec; 41():101629. PubMed ID: 31706098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
    Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
    Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
    Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
    Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease.
    Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H
    Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.
    Oleksy C; Massart F; Goldwurm S; Arado A; Arena G; Boussaad I; Krüger R
    Stem Cell Res; 2023 Oct; 72():103212. PubMed ID: 37832355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene.
    Zhang H; Ma Y; Yu S; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101611. PubMed ID: 31707209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.